Vimarsana
Biggest News Aggregation in the World

Page 8 - Rhinitis News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Rhinitis. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Rhinitis Today - Breaking & Trending Today

Cohort Study Analyzes AD Risk Associated With Parental Atopy - Vimarsana News

Cohort Study Analyzes AD Risk Associated With Parental Atopy

The analysis of AD risk associated with parental atopy in early life "may help to risk stratify infants to optimize early interventions for prevention or early treatment of AD," the authors write.

Study Finds 7 Apps for Rhinitis and Rhinosinusitis With Evidence - Vimarsana News

Study Finds 7 Apps for Rhinitis and Rhinosinusitis With Evidence

Mobile health apps can collect real-world data and assist in rhinitis and rhinosinusitis management, but a new study suggests that more work is needed to validate their clinical applicability.

Altamira Therapeutics Reaches Midpoint for Enrollment in Clinical Trial with Bentrio in Seasonal Allergic Rhinitis in Australia - Vimarsana News

Altamira Therapeutics Reaches Midpoint for Enrollment in Clinical Trial with Bentrio in Seasonal Allergic Rhinitis in Australia

Swift progress of study enrollment - midpoint of 50 patients reachedInterim analysis confirmed target enrollment of 100 patientsCompletion of enrollment expected by early January 2023HAMILTON, BERMUDA

Rhinitis Patients Report Symptomatic Medication Use - Vimarsana News

Rhinitis Patients Report Symptomatic Medication Use

A mobile app used to capture control of allergic rhinitis may favor those who are more tech savvy, say critics.

Add Tezepelumab to SCIT to Improve Cat Allergy Symptoms? - Vimarsana News

Add Tezepelumab to SCIT to Improve Cat Allergy Symptoms?

Adding tezepelumab to cat allergy shots may provide better, longer-lasting symptom relief than allergy shots alone for patients with allergic rhinitis due to cat allergens, researchers report.